Mechanisms of SARS-CoV-2-associated anosmia
Anosmia, the loss of the sense of smell, is one of the main neurological manifestations of COVID-19. Although the SARS-CoV-2 virus targets the nasal olfactory epithelium, current evidence suggests that neuronal infection is extremely rare in both the olfactory periphery and the brain, prompting the need for mechanistic models that can explain the widespread anosmia in COVID-19 patients. Starting from work identifying the non-neuronal cell types that are infected by SARS-CoV-2 in the olfactory system, we review the effects of infection of these supportive cells in the olfactory epithelium and in the brain and posit the downstream mechanisms through which sense of smell is impaired in COVID-19 patients. We propose that indirect mechanisms contribute to altered olfactory system function in COVID-19-associated anosmia, as opposed to neuronal infection or neuroinvasion into the brain. Such indirect mechanisms include tissue damage, inflammatory responses through immune cell infiltration or systemic circulation of cytokines, and downregulation of odorant receptor genes in olfactory sensory neurons in response to local and systemic signals. We also highlight key unresolved questions raised by recent findings.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2023 |
---|---|
Erschienen: |
2023 |
Enthalten in: |
Zur Gesamtaufnahme - volume:103 |
---|---|
Enthalten in: |
Physiological reviews - 103(2023), 4 vom: 01. Okt., Seite 2759-2766 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Tsukahara, Tatsuya [VerfasserIn] |
---|
Links: |
---|
Themen: |
Anosmia |
---|
Anmerkungen: |
Date Completed 03.10.2023 Date Revised 23.03.2024 published: Print-Electronic Citation Status MEDLINE |
---|
doi: |
10.1152/physrev.00012.2023 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM358435498 |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | NLM358435498 | ||
003 | DE-627 | ||
005 | 20240323234612.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231226s2023 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1152/physrev.00012.2023 |2 doi | |
028 | 5 | 2 | |a pubmed24n1342.xml |
035 | |a (DE-627)NLM358435498 | ||
035 | |a (NLM)37342077 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Tsukahara, Tatsuya |e verfasserin |4 aut | |
245 | 1 | 0 | |a Mechanisms of SARS-CoV-2-associated anosmia |
264 | 1 | |c 2023 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 03.10.2023 | ||
500 | |a Date Revised 23.03.2024 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a Anosmia, the loss of the sense of smell, is one of the main neurological manifestations of COVID-19. Although the SARS-CoV-2 virus targets the nasal olfactory epithelium, current evidence suggests that neuronal infection is extremely rare in both the olfactory periphery and the brain, prompting the need for mechanistic models that can explain the widespread anosmia in COVID-19 patients. Starting from work identifying the non-neuronal cell types that are infected by SARS-CoV-2 in the olfactory system, we review the effects of infection of these supportive cells in the olfactory epithelium and in the brain and posit the downstream mechanisms through which sense of smell is impaired in COVID-19 patients. We propose that indirect mechanisms contribute to altered olfactory system function in COVID-19-associated anosmia, as opposed to neuronal infection or neuroinvasion into the brain. Such indirect mechanisms include tissue damage, inflammatory responses through immune cell infiltration or systemic circulation of cytokines, and downregulation of odorant receptor genes in olfactory sensory neurons in response to local and systemic signals. We also highlight key unresolved questions raised by recent findings | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Research Support, N.I.H., Extramural | |
650 | 4 | |a Research Support, Non-U.S. Gov't | |
650 | 4 | |a Review | |
650 | 4 | |a COVID-19 | |
650 | 4 | |a SARS-CoV-2 | |
650 | 4 | |a anosmia | |
650 | 4 | |a neuroinflammation | |
650 | 4 | |a olfaction | |
700 | 1 | |a Brann, David H |e verfasserin |4 aut | |
700 | 1 | |a Datta, Sandeep Robert |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Physiological reviews |d 1945 |g 103(2023), 4 vom: 01. Okt., Seite 2759-2766 |w (DE-627)NLM000076066 |x 1522-1210 |7 nnns |
773 | 1 | 8 | |g volume:103 |g year:2023 |g number:4 |g day:01 |g month:10 |g pages:2759-2766 |
856 | 4 | 0 | |u http://dx.doi.org/10.1152/physrev.00012.2023 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 103 |j 2023 |e 4 |b 01 |c 10 |h 2759-2766 |